Calian Group Ltd. · TSX:CGY
Calian — Non-Deal Roadshow (March 2023)
85 slides from Calian's roadshow presentation, Mar 8, 2023
Slide 1: Investor Presentation
Investor Presentation Toronto Roadshow in collaboration with RBC March 8, 2023 1
Slide 2: Caution Regarding Forward Looking Statements
Caution Regarding Forward Looking Statements Certain information included in this document is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally ac
Slide 3: Table of Contents
Table of Contents 1 ELEVATOR PITCH 2 OVERVIEW OF CALIAN 3 EXECUTING ON OUR GROWTH OBJECTIVE 4 DEPLOYING CAPITAL EFFECTIVELY 5 FUNDING GROWTH 6 FOUR-PISTON ENGINE (OPERATING SEGMENTS) 7 Q1-23 RESULTS 8 WHY INVEST IN CALIAN? 3
Slide 4: Elevator Pitch
Elevator Pitch 4
Slide 5: Calian – FY22 Snapshot
Calian – FY22 Snapshot 40 years 4,500 Ottawa $649M CGY History Workforce Head Office Market Cap TSX 30% 26% ITCS Advanced Technologies REVENUE SEGMENTATION Customers Geography Technology $582M 53% 29% 27% 2022 Revenues Commercial International Products 47% 71% 73% Government Canada Services 16% 29%
Slide 6: Four-Piston Engine
Four-Piston Engine 30% 29% 26% 16% ITCS Health Advanced Technologies Learning $173M $167M $150M $92M 2022 Revenues 2022 Revenues 2022 Revenues 2022 Revenues • On-demand Talent & • Healthcare Professional Services • Space • Domestic Defence Government Solutions • Defence • Pharmaceutical Industry Sol
Slide 7: Four Pillars of Growth
Four Pillars of Growth 5% 5% 10% Organic Growth + Acquisitive Growth = Target Growth 1 2 3 4 Customer Retention Customer Diversification Innovation Continuous Improvement Through continued delivery Through continued Through continued investment Through continued leverage of excellence, each segment
Slide 8: Growing Revenues, Profitability and Margins
Growing Revenues, Profitability and Margins Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 582 180 169 40.0% 70 66 160 60 22.0% 518 52 140 127 35.0% 432 50 120 17.0% 343 89 29.1% 30.0% 40 37 305 100 75 27 1
Slide 9: Generating Increasing Operating FCF
Generating Increasing Operating FCF Adj. EBITDA2 Operating Free Cash Flow (OFCF)1&2 OFCF Conversion1&2 (in millions of $) (in millions of $) (in %) 70 66 76% 47 72% 60 66% 52 63% 50 35 50% 40 37 28 30 25 27 17 13 20 10 0 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2) T
Slide 10: Deploying Capital to Maximize Shareholder Return
Deploying Capital to Maximize Shareholder Return 1 Acquisitions 2 Dividends 3 Capex1 (in millions of $) (in millions of $) (in millions of $) 13 66 12 8 7 10 7 49 9 9 6 5 29 21 5 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 1) Capex = Equipment and application software
Slide 11: Maintaining a Strong Balance Sheet
Maintaining a Strong Balance Sheet Total Debt Cash & Cash Equivalents Net Liquidity (in millions of $) (in millions of $) (in millions of $) 79 159 13 5X Avg. multiple paid upfront 115 (trailing EBITDA) 8 43 84 62 24 22 44 17 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022
Slide 12: Capital Market Profile
Capital Market Profile CGY $80.00 400,000 $66.79 TSX Close 350,000 $70.00 300,000 8 $60.00 $53.42 Analysts 250,000 52-week Low $50.00 200,000 11.7M 150,000 $71.58 $40.00 # Shares 52-week High 100,000 $30.00 50,000 20,141 $779M $20.00 0 Avg. Daily Volume 2-Jan-18 2-Jul-18 2-Jan-19 2-Jul-19 2-Jan-20 2
Slide 13: Overview of Calian
Overview of Calian 13
Slide 14: Calian – FY22 Snapshot
Calian – FY22 Snapshot 40 years 4,500 Ottawa $649M CGY History Workforce Head Office Market Cap TSX 30% 26% ITCS Advanced Technologies REVENUE SEGMENTATION Customers Geography Technology $582M 53% 29% 27% 2022 Revenues Commercial International Products 47% 71% 73% Government Canada Services 16% 29%
Slide 15: Key Milestones in 40-Year History
Key Milestones in 40-Year History 2021 Acquisition 1993 2015 Dapasoft/iSecurity 1982 2004 2019 Calian Technology Acquisition Strategic Health KevIn Ford Calian Bought deal public Ltd. Established Skywave Contract win for becomes announces offering of $80M at DND (HSSC) President and 4-segment Initia
Slide 16: Senior Leadership Team
Senior Leadership Team Kevin Ford Patrick Houston Michele Bedford Sean Hamer Sue Ivay Michael Muldner CEO CFO & Corporate Secretary CCO CTO CHRO CIO Patrick Thera Gordon McDonald Derek Clark Sacha Gera Don Whitty Advanced Technologies Health (Outgoing) Health (Incoming) IT & Cyber Solutions Learning
Slide 17: Four-Piston Engine
Four-Piston Engine 30% 29% 26% 16% ITCS Health Advanced Technologies Learning $173M $167M $150M $92M 2022 Revenues 2022 Revenues 2022 Revenues 2022 Revenues • On-demand Talent & • Healthcare Professional Services • Space • Domestic Defence Government Solutions • Defence • Pharmaceutical Industry Sol
Slide 18: Global Footprint
Global Footprint Our four-piston engine is gaining a growing global footprint 18
Slide 19: Recent News
Recent News • Feb. 24/23 - Calian recognized as an Elite 150 on CRN’s Managed Service Provider (MSP) 500 list for 2023 (ITCS) • Feb. 10/23 – Calian achieves new Microsoft Solutions Partner Designations for Data and AI, Digital and App Innovation and Modern Work (ITCS) • Feb. 10/23 – Calian announces
Slide 20: Capital Market Profile
Capital Market Profile CGY $80.00 400,000 $66.79 TSX Close 350,000 $70.00 300,000 8 $60.00 $53.42 Analysts 250,000 52-week Low $50.00 200,000 11.7M 150,000 $71.58 $40.00 # Shares 52-week High 100,000 $30.00 50,000 20,141 $779M $20.00 0 Avg. Daily Volume 2-Jan-18 2-Jul-18 2-Jan-19 2-Jul-19 2-Jan-20 2
Slide 21: Inaugural ESG Report
Inaugural ESG Report Calian ESG efforts aligned to several United Nations SDGs 21
Slide 22: Executing on our Growth Objective
Executing on our Growth Objective 22
Slide 23: Four Pillars of Growth
Four Pillars of Growth 5% 5% 10% Organic Growth + Acquisitive Growth = Target Growth 1 2 3 4 Customer Retention Customer Diversification Innovation Continuous Improvement Through continued delivery Through continued Through continued investment Through continued leverage of excellence, each segment
Slide 24: Growing Revenues, Profitability and Margins
Growing Revenues, Profitability and Margins Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 582 180 169 40.0% 70 66 160 60 22.0% 518 52 140 127 35.0% 432 50 120 17.0% 343 89 29.1% 30.0% 40 37 305 100 75 27 1
Slide 25: Diversifying Revenue Streams
Diversifying Revenue Streams Geography Offering Customer 20% 19% 25% 22% 18% 20% 25% 27% 29% 33% 32% 31% 47% 49% 53% 80% 81% 75% 78% 82% 80% 75% 73% 71% 67% 68% 69% 53% 51% 47% 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 Canada International Service Product Government
Slide 26: Surpassing 10% Annual Revenue Growth Objective
Surpassing 10% Annual Revenue Growth Objective Acquisitive Revenue Growth Total Revenue Growth Organic Revenue Growth (in %) (in %) (in %) 19% 21% 26% 12% 20% 11% 12% 12% 8% 8% 5% 5% 7% 3% 10% 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 -6% Lapping tough year in Health
Slide 27: Delivering on Guidance
Delivering on Guidance Revenues Adj. EBITDA1 Adj. Net Profit1 (in millions of $) (in millions of $) (in millions of $) 630-680 70-75 46-50 582 518 66 44 432 52 37 343 37 24 27 19 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 1) This is a non-GAAP measure. Please refer
Slide 28: Driving Future Revenues
Driving Future Revenues Backlog New Contract Signings Book-to-Bill Ratio (in billions of $) (in millions of $) 699 1.3 1.33 1.31 1.29 1.2 1.27 1.1 1.23 492 442 447 0.9 0.9 270 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 New contract signings exceed revenues 28
Slide 29: Reaching $1 Billion of Revenues
Reaching $1 Billion of Revenues Continue to deliver double digit growth Leverage high growth opportunities • Strong FCF • Enhanced cross selling • Increasing margins • Larger M&A deals • Growing into new customers • Focus on high organic growth assets Today Run Rate - End FY25 We have the track reco
Slide 30: Deploying Capital Effectively
Deploying Capital Effectively 30
Slide 31: Generating Increasing Operating FCF
Generating Increasing Operating FCF Adj. EBITDA2 Operating Free Cash Flow (OFCF)1&2 OFCF Conversion1&2 (in millions of $) (in millions of $) (in %) 70 66 76% 47 72% 60 66% 52 63% 50 35 50% 40 37 28 30 25 27 17 13 20 10 0 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2) T
Slide 32: Managing Working Capital Requirements
Managing Working Capital Requirements 700 Net WC as a % Revenue 40.0% (in millions of $, except %) Net Working Capital1 582 35.0% Revenues (in millions of $) 600 (in millions of $) 518 30.0% 582 92 500 90 432 518 80 25.0% 400 432 343 21.2% 20.0% 57 305 343 300 17.4% 305 16.6% 46 15.1% 15.0% 13.8% 20
Slide 33: Deploying Capital to Maximize Shareholder Return
Deploying Capital to Maximize Shareholder Return 1 Acquisitions 2 Dividends 3 Capex1 (in millions of $) (in millions of $) (in millions of $) 13 66 12 8 7 10 7 49 9 9 6 5 29 21 5 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 1) Capex = Equipment and application software
Slide 34: Describing M&A Strategy
Describing M&A Strategy • Profitable & growing • Dedicated M&A team • Strategic fit (complementary/scale) • Pipeline: ~10 deals/quarter • Cultural fit • Target closing: ~2-3 deals/year (larger transactions) • Disciplined valuation (do not overpay) • Individual bids & competitive bids Comfortable wit
Slide 35: Completing EBITDA Accretive Acquisitions
Completing EBITDA Accretive Acquisitions TRANSACTION VALUE DATE ACQUISITION SEGMENT GEOGRAPHY (in millions) TOTAL UPFRONT EARNOUT Q2-22 Computex ITCS U.S. $38.0 $38.0 $0.0 Q1-22 SimFront Learning Canada $15.0 $9.0 $6.0 Q2-21 Dapasoft ITCS Canada $83.0 $50.0 (cash & shares) $33.0 (cash & shares) Q2-2
Slide 36: Performing Post Acquisition
Performing Post Acquisition Actions How? • Ability to identify good targets and 9 >$200M 5X complete successful deals Acquisitions Capital deployed Avg. multiple paid upfront (avg. of 2 deals/year) (increasing from <$5M to $80M) (trailing EBITDA) • Deal structure that enables growth • Identification
Slide 37: Maintaining Dividend Payment History
Maintaining Dividend Payment History Dividends & Dividends/Share Dividend Yield Dividend/OFCF1&2 (in millions of $ & in dollars) (in %) (in %) 14 13 68% 1.80 12 12 1.60 3.7% Target range: 10 1.40 3.2% 51% 25%-30% 10 9 9 1.20 8 1.12 1.12 1.12 1.12 1.12 36% 1.00 2.0% 35% 6 0.80 1.7% 1.8% 27% 4 0.60 0.
Slide 38: Optimizing Capex Spending While Growing
Optimizing Capex Spending While Growing Equipment & Application Capitalized R&D1 R&D Expensed Software1 (in millions of $) (in millions of $) (in millions of $) 1.8 5.4 7.4 4.7 5.0 7.1 5.4 1.2 1.1 4.6 3.0 2.0 0.4 1.4 0.2 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 1) C
Slide 39: Ramping Up Deals in Equity Investments
Ramping Up Deals in Equity Investments ECO System Investments Example • Geographical expansion and entry into new • Field Effect Cyber Range – a simulation-based cyber security markets necessitates greater partnership training platform used to grow individual skills, rehearse and eco-system to bring
Slide 40: Funding Growth
Funding Growth 40
Slide 41: Maintaining a Strong Balance Sheet
Maintaining a Strong Balance Sheet Total Debt Cash & Cash Equivalents Net Liquidity (in millions of $) (in millions of $) (in millions of $) 79 159 13 5X Avg. multiple paid upfront 115 (trailing EBITDA) 8 43 84 62 24 22 44 17 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022
Slide 42: Ensuring Available Liquidity
Ensuring Available Liquidity Credit Facility Cash & Cash Equivalents Cash Available (in millions of $) (in millions of $) (in millions of $) 79 40 40 40 40 43 84 24 62 159 22 17 44 115 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 Used Unused Accordian Net Liquidity Acco
Slide 43: Leveraging Capital Structure
Leveraging Capital Structure Capital Structure Bought Deals (Equity) Operating FCF/share1 (in millions of $) (in $) (in millions of $) $4.16 80 8 5X 69 $3.27 $3.08 Avg. multiple paid upfront (trailing EBITDA) $2.19 305 $1.66 292 Pursue strategic growth 13 initiatives and for general 200 corporate &
Slide 44: Four-Piston Engine (Operating Segments)
Four-Piston Engine (Operating Segments) 44
Slide 45: ITCS – FY22 Snapshot
ITCS – FY22 Snapshot ~475 8% / 102% 17% $205M $97M Workforce Organic/Acquisitive Growth EBITDA % New Contract Signings Backlog 26% XaaS and Cyber MDR REVENUE SEGMENTATION 31% Customers Geography Offering IT Solution $173M Provider ~65% ~45% 36% 2022 Revenues Commercial International Products ~35% ~5
Slide 46: ITCS – Financial Performance
ITCS – Financial Performance Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 173 70.0 50.0%35.0 25.0% 61.1 29.5 45.0% 60.0 30.0 40.0% 20.0% Computex 50.0 35.3% 17.1% 35.0%25.0 acquisition 40.0 30.0%20.0 15.0
Slide 47: ITCS – Business Description
ITCS – Business Description 43% 31% 26% On-demand Talent and Government Solutions IT Solution Provider XaaS & Cyber MDR PROBLEM SOLVED: PROBLEM SOLVED: PROBLEM SOLVED: • Talent Scarcity • Cloud Transformation • IT & Cyber Scale • Physical Security • Hybrid Work • Geographic Coverage • Government Com
Slide 48: ITCS – Brands That Trust Us
ITCS – Brands That Trust Us Manufacturing & Retail and Transportation Energy Finance Healthcare Tech and Defence Public Sector Real Estate >1,100 customers to mine for cross-sell and up-sell, at the beginning of this upside 48
Slide 49: ITCS – Business Model
ITCS – Business Model On-Demand Talent and IT Solution Provider XaaS & Cyber MDR Government Solutions Number • ~50 • ~1,100 • ~300 Size • Public Sector (government) • Mid-Market & Enterprise • Mid-Market Customers • ICT OEMs • Public sector (SLED) • Publc sector (hospitals) Geography • Canada • U.S.
Slide 50: ITCS – Recent Acquisitions
ITCS – Recent Acquisitions Secure Technologies provides Computex is a leading Dapasoft is a leading provider EMSEC specializes in Radio world-class cyber security Managed IT and Cybersecurity of innovative systems Frequency (RF) emission solutions such as those from solutions provider with a integra
Slide 51: ITCS – Growth Focus & Competitive Advantages
ITCS – Growth Focus & Competitive Advantages Growth Focus Competitive Advantages 1. Talent and ability to source & scale including government secret cleared 2. N.A. geographic and vertical market focus 3. Breadth/depth of portfolio, sales distribution engine 4. Strategic partners: CRWD, MSFT, CSCO,
Slide 52: Health – FY22 Snapshot
Health – FY22 Snapshot ~1,550 -14% / 0% 17% $154M $707M Workforce Organic / Acquisitive Growth EBITDA % New Contract Signings Backlog 4% In-store Health Clinics 18% REVENUE SEGMENTATION Pharmaceutical Industry Solutions Customers Geography Offering 78% ~42% ~5% 0% $167M Healthcare Commercial Interna
Slide 53: Health – Financial Performance
Health – Financial Performance Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 195 55.0 40 50.0% 30.0% 47.8 34.8 163 167 45.0% 35 45.0 41.6 25.0% 40.0% 30 28.3 35.0 32.4 35.0% 23.4 116 25 20.0% 30.0% 18.5 99
Slide 54: Health – Business Description
Health – Business Description 78% 18% 4% Healthcare Professional Services Pharmaceutical Industry Solutions In-store Health Clinics Manage a network of more than 2,800 Provide clinical trial management services, Design, build and manage all in-store healthcare professionals delivering primary specia
Slide 55: Health – Brands That Trust Us
Health – Brands That Trust Us The defence industry represents over 50% of Health segment revenues 55
Slide 56: Health – Business Model
Health – Business Model Healthcare Professional Services Pharmaceutical Industry Solutions In-Store Health Clinics Number >50 >120 products 1 Customers Size Large (public sector) Multi-national large corporations Large national customer (Loblaws) Geography Canada Canada, International Canada Vertica
Slide 57: Health – Recent Acquisitions
Health – Recent Acquisitions Allphase Clinical Research Inc is a full- Priority One provides specialized Alio Health specializes in the design and service, Contract Research Organization psychological assessment and selection implementation of comprehensive Patient (CRO) providing high quality clini
Slide 58: Health – Growth Focus & Competitive Advantages
Health – Growth Focus & Competitive Advantages Growth Focus Competitive Advantages 1. Speed and reliability 2. Feature-rich Digital Health Enterprise Management platform (leverage Nexi) 3. Reduction of costs of operation in the pharmaceutical industry (leverage Nexi) 4. Industry-leading KPIs 5. Reim
Slide 59: Advanced Tech. – FY22 Snapshot
Advanced Tech. – FY22 Snapshot ~925 -10% / 0% 14% $184M $168M Workforce Organic / Acquisitive Growth EBITDA % New Contract Signings Backlog 22% Defense REVENUE SEGMENTATION Customers Geography Offering $150M 53% ~79% ~70% 62% Space Commercial International Products 2022 Revenues ~21% ~30% 38% 25% Go
Slide 60: Advanced Tech. – Financial Performance
Advanced Tech. – Financial Performance Margin increase due Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) to mix (in millions of $, except margin) (in millions of $) 167 50.0 25.0 30.0% 150 45.0 41.6 43.3 50.0% 21.0 20.9 20.7 153 40.0 20.0 17.7 25.0% 34.0 40.
Slide 61: Advanced Tech. – Business Description
Advanced Tech. – Business Description 53% 25% 22% Space Terrestrial Defence Global leader in the provision of sophisticated ground-based Provides solutions oriented to a variety of markets. Defence engineering services, solutions and products. solutions to the satellite industry for over 55 years. •
Slide 62: Advanced Tech. – Brands That Trust Us
Advanced Tech. – Brands That Trust Us Space Terrestrial Defence Customers come to us when failure is not an option 62
Slide 63: Advanced Tech. – Business Model
Advanced Tech. – Business Model Space Terrestrial Defence Number >100 >500 >10 Size Mixed Mixed Large defence primes Customers Geography Global Global – mostly North American and Europe Mostly North American and Europe Verticals • Communications • GNSS • Military vehicles components and assemblies •
Slide 64: Advanced Tech. – Recent Acquisitions
Advanced Tech. – Recent Acquisitions Intragrain offers advanced SatService offers innovative Tallysman offers the widest InterTronic Solutions produces tools to monitor grain and engineering solutions and range of precision and high performance antenna fuel storage products for the satellite custom
Slide 65: Advanced Tech. – Growth Focus & Competitive Advantages
Advanced Tech. – Growth Focus & Competitive Advantages Growth Focus Competitive Advantages 1. Provide antenna solutions to meet or exceed customer requirements at an attractive price 2. Support our customers from pre-sales engineering through to product end-of-life 3. Collaborate with our customers
Slide 66: Learning – FY22 Snapshot
Learning – FY22 Snapshot ~1,375 7% / 16% 18% $154M $328M Workforce Organic / Acquisitive Growth EBITDA % New Contract Signings Backlog 10% Commercial REVENUE SEGMENTATION 15% Global Customers Geography Offering Defence 75% ~10% ~15% 4% $92M Domestic Commercial International Products 2022 Revenues De
Slide 67: Learning – Financial Performance
Learning – Financial Performance Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 92 25.0 23.3 50.0% 18.0 16.9 30.0% 45.0% 16.0 75 20.0 17.3 40.0% 14.0 25.0% Simfront 12.4 62 63 35.0% 58 acquisition 12.0 15.0
Slide 68: Learning – Business Description
Learning – Business Description 75% 15% 10% Domestic Defence Global Defence Commercial Provides simulation-based training for Provides a range of military training for Develops and delivers more engaging, • VCCI – Virtual Command the Canadian Armed Forces. This includes NATO member countries, includ
Slide 69: Learning – Brands That Trust Us
Learning – Brands That Trust Us Leveraging NATO relationships to gain new opportunities in Europe 69
Slide 70: Learning – Business Model
Learning – Business Model Domestic Defence Global Defence Commercial Number < 20 <20 >25 Size Large Medium and Large Medium and Large organizations Customers Geography Canada NATO, NATO Nations, Australia, Africa North America Verticals • Defence • Defence • Government & Crown Corporations • Learnin
Slide 71: Learning – Recent Acquisitions
Learning – Recent Acquisitions Specializes in training, simulation CTS is a Norway based training firm Cadence is a specialized professional technologies and integrating that develops and delivers complex training and consulting firm with platforms focused on strengthening training exercises for the
Slide 72: Learning – Growth Focus & Competitive Advantages
Learning – Growth Focus & Competitive Advantages Growth Focus Competitive Advantages 1. We have experience and credibility 2. The only military training leader to provide end-to-end synthetic training solutions for high-readiness and collective training 3. Our solution is system-agnostic and interop
Slide 73: Q1-23 Results
Q1-23 Results 73
Slide 74: Q1-23 Consolidated Results
Q1-23 Consolidated Results $126M $1.3B -2% 16% New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 60 40.0% 161 50 20.0 19.1 142 150 148 46 22.0% 5
Slide 75: Q1-23 ITCS
Q1-23 ITCS $46M $102M 11% 89% New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 69 30 65.0% 14.0 35.0% 12.4 25.1 60.0% 25 12.0 55.0% 30.0% 49 46
Slide 76: Q1-23 Health
Q1-23 Health $34M $690M -5% -% New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 10.0 40.0% 35.0% 14.0 9.0 45 7.9 8.0 30.0% 42 12.0 11.0 11.3 8.0
Slide 77: Q1-23 Advanced Technologies
Q1-23 Advanced Technologies $42M $167M -17% -% New Contract Signings Backlog Organic Growth Acquisitive Growth Gross Profit & Margin Adj. EBITDA1 & Margin1 Revenues (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 11.9 45.0% 7.0 12 10.7 11.2 11.2 41 10.2 6.0 5.5
Slide 78: Q1-23 Learning
Q1-23 Learning $4M $307M 16% -% New Contract Signings Backlog Organic Growth Acquisitive Growth Gross Profit & Margin Adj. EBITDA1 & Margin1 Revenues (in millions of $, except margin) (in millions of $) (in millions of $, except margin) 8.0 6.0 40.0% 5.4 26 6.8 6.6 32.0% 25 7.0 23 5.9 5.0 22 22 5.7
Slide 79: Q1-23 - Operating FCF Generation & Conversion
Q1-23 - Operating FCF Generation & Conversion Adj. EBITDA2 Operating Free Cash Flow (OFCF)1&2 OFCF Conversion1&2 (in millions of $) (in millions of $) (in %) 85% 19.1 14.1 78% 74% 16.8 13.1 12.1 70% 16.1 14.0 14.3 63% 9.8 10.2 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q
Slide 80: Q1-23 – Capital Deployment
Q1-23 – Capital Deployment Acquisitions Dividends Capex1 (in millions of $) (in millions of $) (in millions of $) 48 3 3 3 3 3 2 2 2 1 1 10 4 4 3 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 1) Capex = Equipment and application software + Capitalized R&D
Slide 81: Q1-23 - Balance Sheet
Q1-23- Balance Sheet Total Debt Cash & Cash Equivalents Net Liquidity (in millions of $) (in millions of $) (in millions of $) 147 25 67 131 59 58 124 114 115 51 43 8 8 8 0 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 1) Net Liquidity= Unused portion of c
Slide 82: FY23 – Guidance Reiterated
FY23 – Guidance Reiterated Revenues Adj. EBITDA1 Adj. Net Profit1 (in millions of $) (in millions of $) (in millions of $) 630-680 70-75 46-50 582 518 66 44 432 52 37 343 37 24 27 19 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 1) This is a non-GAAP measure. Please r
Slide 83: Why Invest in Calian?
Why Invest in Calian? 83
Slide 84: Investment Value Proposition
Investment Value Proposition 1 REVENUE DIVERSIFICATION 6 HIGH FCF CONVERSION RATE 2 STRONG BALANCE SHEET 7 SOLID BACKLOG 3 SUCCESSFUL M&A STRATEGY 8 FOCUS ON ORGANIC GROWTH 4 EXPANDING MARGINS 9 GROWING EQUITY INVESTMENTS 5 POSTIVE TRENDS IN END MARKETS 10 10 AMPLE DRY POWDER TO GROW Established Man
Slide 85: Thank you
See CALIAN . Thank you ir@calian.com